Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.
Objective: Evaluate the quality of life and the presence of anxiety and depression in HFS patients and their behavior after botulinum toxin administration. Background: Hemifacial…Precision Functional MRI Mapping of Therapeutic Response in Focal Hand Dystonia
Objective: To apply precision functional mapping (PFM) to characterize individual-specific network changes in persons with focal hand dystonia (FHD) before and after botulinum toxin (BTX)…Comparative Effectiveness of Botulinum Toxin vs. Oral Medications in the Management of Cervical Dystonia: A Multi-Center Study
Objective: This study aims to compare the effectiveness of botulinum toxin injections versus oral medications in the symptomatic management of cervical dystonia , evaluating their…How Botulinum Toxin Transformed the American Food Industry
Objective: To highlight an episode of botulism that altered American food packaging technology Background: Early progress in understanding the behavior of botulinum toxin was marked…Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review
Objective: To evaluate the cost-effectiveness of Botulinum Toxin A in our movement disorder division. Background: Botulinum Toxin A is an FDA-approved treatment for various medical…Topical Botulinum-Toxin-like Alternatives: A Systematic Literature Review
Objective: To perform a systematic review exploring the relevant literature on BoNT and BoNT-like substances in topical form and clinical trials focusing on facial muscle…Individual-specific brain functional connectivity mapping of therapeutic response in task-specific focal dystonia
Objective: Determine therapeutic effects of botulinum toxin on functional connectivity in individuals with task-specific dystonia. Background: Isolated task-specific dystonia occurs during specific activities, but not…Is a Parkinson’s Sialorrhoea service effective?
Objective: Evaluate the efficacy and tolerance of Botulinum Toxin A (BoNT A) in managing sialorrhoea in People with Parkinsons (PwP)Assess impact on quality of life…AbobotulinumtoxinA: evidence for long duration of response
Objective: To assess clinical treatment intervals and duration of response for abobotulinumtoxinA in the management of pediatric and adult spasticity and assess preclinical data that…Benefit and Weakness with botulinum toxin: time course and relationship.
Objective: To compare the timecourse of and relationship between benefit and weakness after botulinum toxin (BoNT) injection. Background: The timecourse of benefit onset and duration…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.